| Not Yet Recruiting | Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria NCT07431931 | Geisinger Clinic | N/A |
| Not Yet Recruiting | Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria NCT07224776 | Brigham and Women's Hospital | Phase 1 |
| Not Yet Recruiting | Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlot NCT07358520 | Fudan University | Phase 4 |
| Not Yet Recruiting | Huaier Granule and Proteinuria NCT07355361 | Fudan University | Phase 2 |
| Not Yet Recruiting | CHART-C3G/CLNP023B12011 NCT07331259 | Novartis Pharmaceuticals | — |
| Recruiting | Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis NCT07219121 | Travere Therapeutics, Inc. | Phase 4 |
| Recruiting | Nefecon and Ambrisentan in IgA Nephropathy NCT07030894 | The First Hospital of Jilin University | Phase 4 |
| Not Yet Recruiting | Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Mu NCT06792448 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease NCT06923709 | Odense University Hospital | Phase 2 |
| Recruiting | Effects of Exogenous Ketosis on Proteinuria and Renal Function NCT06867471 | Gødstrup Hospital | N/A |
| Not Yet Recruiting | Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan NCT06491940 | RESnTEC, Institute of Research | N/A |
| Enrolling By Invitation | Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients NCT06588465 | China Medical University Hospital | N/A |
| Completed | Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease NCT05759754 | Children's Hospital of Fudan University | N/A |
| Completed | KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients. NCT07260292 | National Chung Hsing University | N/A |
| Unknown | Azilsartan in Patients With Diabetic Kidney Disease and Hypertension NCT05753696 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Completed | Effect of Low Salt and Ckd Progression NCT05716386 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | N/A |
| Recruiting | ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank NCT06162546 | Christoph Aufricht | — |
| Completed | Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy NCT06460987 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | — |
| Recruiting | A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE NCT05457283 | Bayer | Phase 3 |
| Completed | Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria NCT05314231 | Alexion Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, NCT05196035 | Bayer | Phase 3 |
| Unknown | Effects of Nitrate-rich Beetroot Juice in Pregnant Women With High Blood Pressure NCT05241327 | Karolinska Institutet | N/A |
| Unknown | Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease NCT04939116 | Angion Biomedica Corp | Phase 2 |
| Completed | Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast NCT06088849 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Completed | An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria NCT05086549 | Boryung Pharmaceutical Co., Ltd | — |
| Completed | Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressi NCT07150338 | Neukidney Inc. | — |
| Recruiting | Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) NCT04752293 | Wake Forest University Health Sciences | — |
| Completed | Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. NCT06374043 | University Medical Center Groningen | Phase 4 |
| Withdrawn | Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease NCT04531397 | Children's Hospital of Fudan University | Phase 4 |
| Completed | The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease NCT04874753 | Uşak University | — |
| Completed | Efficacy and Safety of Dapagliflozin in Children With Proteinuria NCT04534270 | Children's Hospital of Fudan University | Phase 4 |
| Completed | Empagliflozin in Patients With Glomerulonephritis NCT05283057 | Kasr El Aini Hospital | Phase 3 |
| Terminated | Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria NCT04171778 | University of Rochester | N/A |
| Terminated | Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury NCT04051957 | The University of Texas Health Science Center, Houston | Phase 2 |
| Unknown | The Association Between Sleep Duration and Sleep Disorders and Proteinuria in Children NCT03933046 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | Sensitivity and Specificity of Urinary Dipstick in Emergency Departments NCT04059211 | Sonderborg Hospital | — |
| Withdrawn | Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury NCT02882373 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Validation of a PrCr Dipstick Diagnostic Test in Ghana NCT03510286 | PATH | — |
| Unknown | HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria NCT03550859 | Yuhan Corporation | Phase 4 |
| Completed | Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria NCT03190694 | Hiddo Lambers Heerspink | Phase 2 |
| Completed | Pharmacokinetics of Apixaban in Nephrotic Syndrome NCT02599532 | University of North Carolina, Chapel Hill | Phase 1 |
| Recruiting | Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCAR NCT02818192 | University of Manitoba | — |
| Unknown | Availability Study of ACTH to Treat Children SRNS/SDNS NCT02972346 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Unknown | Scanadu Urine Device Validation Study Protocol NCT02973178 | Scanadu, Inc. | N/A |
| Completed | Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Unde NCT02798042 | NYU Langone Health | — |
| Unknown | Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease NCT03019848 | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 2 |
| Completed | Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas NCT03983551 | Changhua Christian Hospital | Phase 4 |
| Completed | Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers NCT02780414 | Progenity, Inc. | — |
| Completed | Belatacept Conversion in Proteinuric Kidney Transplant Recipients NCT02327403 | Brigham and Women's Hospital | Phase 2 |
| Completed | Proteinuria During Acute Pyelonephritis In Pregnancy NCT02536638 | MemorialCare Health System | — |
| Unknown | Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) NCT03195023 | Hospital General Universitario Gregorio Marañon | Phase 4 |
| Terminated | Preventing Sickle Cell Kidney Disease NCT02373241 | University of Alabama at Birmingham | Phase 2 |
| Completed | Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression NCT02282930 | Mayo Clinic | Phase 3 |
| Withdrawn | Acthar on Proteinuria in IgA Nephropathy Patients NCT02382523 | Baylor College of Medicine | Phase 4 |
| Unknown | uChek Pilot Study for Urinalysis in the Antenatal Care Setting NCT02256995 | Maternova Research | — |
| Terminated | Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients NCT02057523 | University of Illinois at Chicago | Phase 4 |
| Completed | An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka NCT02226055 | University of Edinburgh | — |
| Completed | Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria NCT02232763 | Seoul National University Hospital | Phase 3 |
| Unknown | A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy NCT02173106 | Sun Yat-sen University | Phase 2 |
| Unknown | Kidney Function in Patients With Bladder Exstrophy NCT02192801 | Tel-Aviv Sourasky Medical Center | — |
| Unknown | Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis NCT02063100 | Chinese PLA General Hospital | Phase 4 |
| Unknown | A Crossover Pilot Study of the Effect of Amiloride on Proteinuria NCT02522650 | Georgetown University | Phase 4 |
| Completed | Hypertension and Urine Protease Activity in Preeclampsia NCT01828138 | Odense University Hospital | N/A |
| Completed | Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis NCT01967355 | Karl Winkler | N/A |
| Unknown | Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD NCT01820832 | Huashan Hospital | Phase 4 |
| Terminated | Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes NCT01804777 | University of New Mexico | EARLY_Phase 1 |
| Completed | Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease NCT01831193 | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 3 |
| Unknown | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturn NCT01760096 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Completed | Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria NCT01694160 | Oslo University Hospital | Phase 3 |
| Completed | RAS Quantification in Patients With Aliskiren or Candesartan NCT01827202 | Medical University of Vienna | Phase 4 |
| Unknown | The Effects of Weight Reduction in IgA Nephropathy NCT01773382 | Chulalongkorn University | N/A |
| Completed | Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients NCT01436747 | University Medical Centre Ljubljana | Phase 3 |
| Unknown | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal H NCT01642979 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Completed | MARCH Renal Substudy NCT01637259 | Kirby Institute | Phase 4 |
| Completed | Paricalcitol in Fabry Disease NCT02090608 | Federico II University | N/A |
| Terminated | Rituximab to Prevent Recurrence of Proteinuria NCT01164098 | George W. Burke | Phase 3 |
| Unknown | Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients NCT01512862 | Seoul National University Hospital | Phase 4 |
| Completed | Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients NCT01386554 | Mallinckrodt | Phase 4 |
| Completed | Bariatric Surgery and the Kidney NCT01410994 | Indiana University | — |
| Completed | N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy NCT01265563 | VA Office of Research and Development | Phase 2 |
| Recruiting | Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy NCT00977977 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Withdrawn | Velcade for Proliferative Lupus Nephritis NCT01169857 | The Rogosin Institute | Phase 4 |
| Completed | Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease NCT01156428 | The Rogosin Institute | — |
| Unknown | Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial NCT01152060 | Nanchang University | — |
| Unknown | Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients NCT01091324 | National Cheng-Kung University Hospital | Phase 3 |
| Completed | Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria NCT01044771 | Metropolis Medical | N/A |
| Completed | The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria NCT01541267 | Medical University of Gdansk | Phase 4 |
| Completed | N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy NCT00915200 | The University of Texas Health Science Center at San Antonio | Phase 2 |
| Completed | The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease NCT01029002 | Albert Einstein College of Medicine | Phase 3 |
| Terminated | Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients NCT00961207 | Cook County Health | Phase 4 |
| Completed | Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria NCT00935389 | Nanjing University School of Medicine | N/A |
| Terminated | Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy NCT00856674 | Osprey Pharmaceuticals USA, Inc. | Phase 1 |
| Completed | Influence of Aliskiren on Proteinuria NCT01219413 | Medical University of Gdansk | Phase 4 |
| Unknown | The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinu NCT00858299 | Samsung Medical Center | Phase 4 |
| Completed | Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosc NCT00801463 | Nanjing University School of Medicine | N/A |
| Unknown | Study of Prevalence of Proteinuria, Urinary Tract Infection or Hematuria in Athletes NCT00912834 | Far Eastern Memorial Hospital | — |
| Withdrawn | The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria NCT00508898 | Chinese University of Hong Kong | Phase 4 |
| Completed | Effect of Turmeric on Diabetic Nephropathy NCT01015937 | Shaheed Faghihi Hospital | N/A |
| Completed | The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, P NCT00921570 | Gulhane School of Medicine | Phase 4 |
| Recruiting | Proteinuria in Pre and Post Transplant NCT01094327 | University of Miami | — |
| Completed | Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) L NCT00893425 | Gulhane School of Medicine | Phase 4 |
| Completed | FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients NCT01703234 | Gulhane School of Medicine | Phase 4 |
| Withdrawn | Sympathetic Overactivity in Essential Hypertension NCT00541619 | University of Erlangen-Nürnberg Medical School | — |
| Completed | Evaluation of Albuminuria HIV-Infected Patients NCT00524992 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Terminated | Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignanc NCT00698659 | National University Hospital, Singapore | — |
| Completed | Sitaxsentan in Proteinuric Chronic Kidney Disease NCT00817037 | University of Edinburgh | Phase 2 |
| Completed | Influence of Pioglitazone for Renal Transplant Function in Diabetics NCT00507494 | Technische Universität Dresden | Phase 3 |
| Completed | An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 NCT00568178 | Organon and Co | Phase 3 |
| Completed | To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Me NCT00550095 | Novartis | Phase 4 |
| Completed | The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study NCT00446862 | University of Alabama at Birmingham | — |
| Completed | Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria NCT00493727 | US Department of Veterans Affairs | N/A |
| Suspended | Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinu NCT00369538 | University Hospital, Strasbourg, France | Phase 4 |
| Completed | Endothelin Receptor Antagonism in Proteinuric Nephropathy NCT00722215 | University of Edinburgh | Phase 1 |
| Completed | The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Protei NCT00674596 | Gulhane School of Medicine | Phase 4 |
| Withdrawn | Impact of Screening Patients With HIV for Kidney Disease NCT00392132 | University of Mississippi Medical Center | — |
| Completed | Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evalua NCT00654771 | University of Pittsburgh | — |
| Completed | Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System NCT00528385 | Medical University of Gdansk | N/A |
| Completed | Optimalization of Nephroprotection Using Atorvastatin (Sortis) NCT00572312 | Medical University of Gdansk | N/A |
| Completed | Optimalization of Nephroprotection Using N-Acetylcysteine NCT00572663 | Medical University of Gdansk | N/A |
| Unknown | Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 NCT00565396 | Shanghai Municipal Health Bureau | N/A |
| Withdrawn | Treatment Targets for Chronic Hypertension in Pregnancy NCT00194974 | Weill Medical College of Cornell University | Phase 1 / Phase 2 |
| Completed | Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) NCT00234871 | Abbott | Phase 4 |
| Completed | Olmesartan Medoxomil and Diabetic Nephropathy NCT00362960 | Sankyo Pharma Gmbh | Phase 3 |
| Completed | High Doses of Candesartan Cilexetil on the Reduction of Proteinuria NCT00242346 | AstraZeneca | Phase 3 |
| Completed | ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial NCT00141453 | Daiichi Sankyo Co., Ltd. | Phase 3 |
| Completed | Statins in Proteinuric Nephropathies NCT00199927 | Mario Negri Institute for Pharmacological Research | Phase 3 |
| Completed | Angiotensin II Blockade for Chronic Allograft Nephropathy NCT00067990 | University of Minnesota | Phase 4 |
| Completed | Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus NCT00241085 | Novartis | Phase 4 |
| Terminated | Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insuffic NCT00338091 | Southern Medical University, China | N/A |
| Completed | Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney NCT00106561 | Melbourne Health | Phase 2 / Phase 3 |
| Completed | Antiproteinuric Agents and Fabry Disease NCT00343577 | University of Alabama at Birmingham | — |
| Completed | Postoperative New-onset Proteinuria and Adverse Outcomes. NCT06339229 | Yaozhong Kong | — |
| Completed | Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) NCT00001959 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Enrolling By Invitation | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV NCT02699736 | Rigshospitalet, Denmark | — |
| Terminated | Determination of Kidney Function NCT00001978 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |